BioNTech (NASDAQ: BNTX) And Pfizer (NYSE: PFE) Files Petition Against CureVac BV (NASDAQ: CVAC) Over Patent Breach

Manufacturer of the COVID-19 vaccine BioNTech (NASDAQ: BNTX) and partner Pfizer (NYSE: PFE) announced on Tuesday that they had lodged a petition with the US District Court in Massachusetts, requesting for a ruling that their actions did not violate US patents claimed by rival CureVac BV (NASDAQ: CVAC). CureVac accused of trying to take advantage […]

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) Receives Regulatory Approval For COVID-19 Vaccine in Younger Teenagers

Pfizer Inc (NYSE: PFE) and BioNTech SE received full regulatory authorization for their COVID-19 Vaccine for adolescents between 12 and 15 years in the US, which is a major milestone that will enable the drug manufacturers to continue marketing the vaccines to teenagers after the pandemic. Pfizer’s COVID-19 vaccine approved for teens between 12-15 years […]

Merck & Co., Inc (NYSE: MRK) Continues Its Expansion With Planned Acquisition of Seagen Inc

Merck & Co., Inc (NYSE: MRK) has announced that it is in discussion to purchase Seagen Inc. and may reach an agreement as earlier as this month, according to people familiar with the matter. Merck to offer $200 per share to buy Seagen One of the sources stated that a sale price of around $200 per […]

Merck & Co. Inc (NYSE: MRK) To Move Forward with Plans To Purchase Seagen Inc

According to sources familiar with the matter, Merck & Co. Inc (NYSE: MRK) is moving forward with a possible acquisition of Seagen Inc.. This would be one of the biggest acquisitions of the year. Merck is in discussions to acquire Seagen to expand the cancer medication lineup Last week, The Wall Street Journal reported that […]

Big Pharma Deals: Pfizer Inc. (NYSE: PFE) Partners with Valneva SE in the Fight against Lyme Disease

One of the big pharma entities in the U.S., Pfizer Inc. (NYSE: PFE), just got into a deal with French jab manufacturer Valneva SE. The timing of this deal couldn’t have come at a better time, given the setback and reputational risks that Valneva has been facing in its Covid-19 vaccine candidate disagreement with the […]

The Food and Drug Administration Recently Consented to Moderna Inc’s (NASDAQ: MRNA) COVID 19 Children Vaccine

The Food and Drug Administration recently authorised the administration of Moderna Inc’s  (NASDAQ: MRNA) coronavirus vaccine to infants or minors. During the announcement, the Authority disclosed that the vaccine was effective and guarded, thus creating the platform for evaluating the agency’s consultancy platforms before the week concludes. The Authority further announced that it would conduct […]

Pfizer Inc. (NYSE: PFE) Has Developed a COVID-19 Vaccine For Children Under 5

Pfizer Inc. (NYSE: PFE) is continuing to make efforts toward protecting young children from COVID-19 infection. The company has recently announced that three shots of its vaccines could offer ample protection for those under five. Pfizer intends to submit its results to regulators. Modern Inc (NASDAQ: MRNA) has developed a vaccine for children under five […]

Pfizer Inc. (NYSE: PFE) Is About to Trade Ex-dividend

Pfizer Inc. (NYSE: PFE) has announced that it will soon trade ex-dividend. This announcement signals the company’s investors to make their moves. The ex-dividend date refers to the day before a company decides which of its shareholders will get a dividend. Pfizer’s dividend will be $0.40 per share. Pfizer announces the real-world benefits of IBRANCE […]

Pfizer Inc. (NYSE: PFE) Finds That Paxlovid Cannot Prevent COVID-19 Infection

Pfizer Inc. (NYSE: PFE) has found that its Paxlovid pill might not effectively prevent COVID-19 in people who have come in contact with infected individuals. Paxlovid is an oral drug which the Food and Drug Administration (FDA) approved for the treatment of COVID-19. In the study, the company gave the pill to people for five […]

Zacks Analyst Look At The Future of Pfizer Inc. (NYSE: PFE)

Zacks Analyst has placed Pfizer Inc. (NYSE: PFE) on the list of the most searched stock. This news is unsurprising as the company has performed well in recent months. Now investors wonder what the future is for the company. Zacks Analyst gives investors an idea of what to expect. For example, analysts believe that the […]

Britain Boosts Access to Pfizer Inc (NYSE: PFE) COVID Antiviral Drug

Britain wishes to protect its citizens by increasing access to the Pfizer Inc (NYSE: PFE) oral antiviral COVID-19 treatment. Its move will benefit thousands, provided it will successfully add the oral antiviral to a trial to establish the best way to use the drug. Britain has done a remarkable job vaccinating a large percentage of […]

Pfizer Inc. (NYSE: PFE) Has Produced 6 Million Paxlovid Pills

Pfizer Inc. (NYSE: PFE) announced that it surpassed the target that Albert Bourla, its CEO, set and developed 6 million Paxlovid pills. Paxlovid is an oral pill that treats COVID-19. The company also stated that it had sent these pills to 26 counties. It hopes to create about 120 million pills in 2022. Meanwhile, the […]

Pfizer Inc. (NYSE: PFE) Gets Breakthrough Therapy Designation For RSVpreF

The U.S Food and Drug Administration (FDA) has given Pfizer Inc. (NYSE: PFE) the Breakthrough Designation for RSVpreF, its vaccine for respiratory syncytial virus (RSV). The vaccine is for people aged 60 and above. This move comes after Pfizer conducted a Phase IIa clinical trial that looked into the efficacy, immunogenicity, and safety of the […]

Pfizer Inc. (NYSE: PFE) Recalls Accuretic For Nitrosamine Contamination

Pfizer Inc. (NYSE: PFE) has recalled some lots of Accuretic, a hypertension drug. The company is also recalling two cheaper versions of Accuretic. This move is due to nitrosamine, which is carcinogenic, in the medication. While Pfizer has said that patients who take the drug are not at immediate risk of developing cancer, taking nitrosamines […]

Pfizer Inc. (NYSE: PFE) Study Shows The Company Gives Equitable Pay to Workers

Pfizer Inc. (NYSE: PFE) has stated for the third time that a compensation expert has recognized that the company offers equitable pay to workers. This announcement came after a study on gender-based pay worldwide and for U.S minorities. It used bonuses, merit increases, and base pay to assess payment equity. The study also adjusted for […]